Don't miss

Replay


LATEST SHOWS

THE INTERVIEW

Erdogan to rid Turkish institutions of ‘separatist cancer’ after coup attempt

Read more

ENCORE!

The best of summer music festivals in France

Read more

FRANCE IN FOCUS

Going for gold: French athletes train for Rio Olympics

Read more

#TECH 24

Digital beauty

Read more

FOCUS

Women doctors in Pakistan challenge the status quo

Read more

BUSINESS DAILY

Trump hopes to reset America's trade relations

Read more

IN THE PAPERS

'Donald Trump's speech was just another scam'

Read more

IN THE PAPERS

Cazeneuve at the heart of Nice security controversy

Read more

EYE ON AFRICA

South Africa: Prosecutors seek longer sentence for Oscar Pistorius

Read more

China seeks volunteers for AIDS vaccine trials

Latest update : 2009-03-21

China, where between 30 and 50 million people may be at risk from the disease, is seeking volunteers to undergo a second phase of human trials on an AIDS vaccine.

AFP - Chinese scientists are seeking volunteers to undergo a second phase of human trials on an AIDS vaccine, state media reported Saturday.

China began research into an AIDS vaccine 13 years ago and conducted its first phase of clinical trials on 49 people aged between 18 and 50 in the Guangxi region of southern China in 2005, the Xinhua news agency said.

"The recipients of the vaccine do not show any signs of adverse effects. Immune tests for the vaccine have also proved favourable results," said Kong Wei, one of the programme's team leaders.

Researchers said they wanted to enroll another 30 volunteers for the second phase of tests for the vaccine, which must undergo three lots of clinical trials before it can be approved for use.

Officially, China had 276,630 AIDS cases in 2008 and 38,100 deaths, but experts say the true figure is much higher as the tally refers only to confirmed incidents of the condition.

UNAIDS estimates that between 30 and 50 million people may be at risk from the disease in China, where transmission through sexual activity is increasingly common.
 

Date created : 2009-03-21

COMMENT(S)